TAFAMIDIS

TAFAMIDIS was reported 12176 times

TAFAMIDIS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NOCTURNAL HYPERTENSION 9 0.4091
1 AMYLOIDOSIS SENILE 13 0.3611
2 FAMILIAL AMYLOIDOSIS 6 0.2727
3 ACQUIRED ATTR AMYLOIDOSIS 11 0.2683
4 CARDIAC AMYLOIDOSIS 215 0.1953
5 HEREDITARY NEUROPATHIC AMYLOIDOSIS 9 0.1667
6 EXERESIS 3 0.1071
7 CONGENITAL CORONARY ARTERY MALFORMATION 16 0.0947
8 GASTROINTESTINAL AMYLOIDOSIS 6 0.0723
9 CHRONIC LEFT VENTRICULAR FAILURE 26 0.0722
10 AMYLOIDOSIS 116 0.0672
11 ATRIAL APPENDAGE CLOSURE 3 0.0600
12 PANCREATIC STEATOSIS 16 0.0588
13 CREATININE URINE ABNORMAL 7 0.0565
14 CARDIAC RESYNCHRONISATION THERAPY 4 0.0563
15 PULMONARY AMYLOIDOSIS 5 0.0543
16 HEART TRANSPLANT 42 0.0464
17 GASTRIC PH INCREASED 5 0.0435
18 URINARY CASTS PRESENT 4 0.0381
19 HEART FAILURE WITH PRESERVED EJECTION FRACTION 9 0.0306
20 CARDIAC FAILURE CHRONIC 122 0.0286
21 URINARY OCCULT BLOOD POSITIVE 5 0.0213
22 CARDIORENAL SYNDROME 11 0.0192
23 BENDOPNOEA 4 0.0182
24 WRONG STRENGTH 6 0.0182
25 ESSENTIAL HYPERTENSION 32 0.0175
26 RESTRICTIVE CARDIOMYOPATHY 5 0.0165
27 CARDIAC SEPTAL HYPERTROPHY 4 0.0144
28 CARDIOVERSION 20 0.0143
29 LICE INFESTATION 3 0.0143
30 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 20 0.0142
31 CARDIAC PACEMAKER INSERTION 83 0.0139
32 EYE INFECTION STAPHYLOCOCCAL 4 0.0138
33 RIGHT ATRIAL DILATATION 7 0.0138
34 AORTIC VALVE REPLACEMENT 17 0.0136
35 SINUS ARRHYTHMIA 17 0.0130
36 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 4 0.0126
37 TRICUSPID VALVE DISEASE 5 0.0125
38 ATRIAL ENLARGEMENT 3 0.0110
39 DYSPNOEA PAROXYSMAL NOCTURNAL 8 0.0110
40 URINARY SEDIMENT PRESENT 7 0.0109
41 LEFT VENTRICULAR DILATATION 5 0.0098
42 BRAIN NATRIURETIC PEPTIDE INCREASED 30 0.0097
43 LEFT VENTRICULAR HYPERTROPHY 41 0.0096
44 HEART FAILURE WITH REDUCED EJECTION FRACTION 5 0.0093
45 FUNGAL FOOT INFECTION 4 0.0091
46 IMPLANTABLE DEFIBRILLATOR INSERTION 12 0.0091
47 CONGESTIVE HEPATOPATHY 4 0.0089
48 ACUTE LEFT VENTRICULAR FAILURE 6 0.0089
49 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13 0.0089
50 SPINAL STENOSIS 36 0.0087
51 CARDIAC PACEMAKER REPLACEMENT 4 0.0087
52 CARDIAC ABLATION 15 0.0084
53 RED BLOOD CELLS URINE POSITIVE 8 0.0083
54 ARTERIAL THROMBOSIS 16 0.0083
55 TYPE V HYPERLIPIDAEMIA 4 0.0082
56 CARDIAC HYPERTROPHY 9 0.0081
57 BODY HEIGHT DECREASED 85 0.0079
58 CARDIAC FAILURE 638 0.0079
59 LEFT ATRIAL DILATATION 10 0.0078
60 QRS AXIS ABNORMAL 6 0.0078
61 RIGHT VENTRICULAR HYPERTROPHY 7 0.0078
62 LEFT ATRIAL ENLARGEMENT 4 0.0074
63 HYPOACUSIS 303 0.0070
64 HEARING AID USER 3 0.0070
65 DILATATION ATRIAL 8 0.0069
66 VASCULAR DEMENTIA 6 0.0068
67 HEART VALVE REPLACEMENT 10 0.0068
68 SYSTOLIC DYSFUNCTION 7 0.0066
69 CARDIAC DEATH 8 0.0066
70 DIZZINESS EXERTIONAL 5 0.0066
71 SINUS NODE DYSFUNCTION 12 0.0065
72 RIGHT VENTRICULAR DYSFUNCTION 7 0.0063
73 FOREIGN BODY IN THROAT 20 0.0063
74 CARDIAC FAILURE ACUTE 42 0.0063
75 HYPERVOLAEMIA 31 0.0063
76 AORTIC VALVE DISEASE 10 0.0062
77 DIASTOLIC DYSFUNCTION 19 0.0061
78 ATRIAL FLUTTER 48 0.0060
79 MARASMUS 9 0.0059
80 AORTIC VALVE CALCIFICATION 3 0.0058
81 ATRIAL THROMBOSIS 12 0.0058
82 DIZZINESS POSTURAL 56 0.0058
83 FLUID IMBALANCE 4 0.0057
84 INFUSION SITE CELLULITIS 3 0.0057
85 ORTHOPNOEA 18 0.0056
86 MACROGLOSSIA 3 0.0055
87 AORTIC STENOSIS 19 0.0055
88 CARPAL TUNNEL SYNDROME 76 0.0054
89 AORTIC DILATATION 6 0.0054
90 FLUID RETENTION 256 0.0050
91 AUDITORY DISORDER 7 0.0049
92 CAROTID ARTERIOSCLEROSIS 5 0.0048
93 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
94 DEMENTIA 131 0.0047
95 LEFT VENTRICULAR FAILURE 16 0.0046
96 BLOOD CHLORIDE INCREASED 8 0.0046
97 TRICUSPID VALVE INCOMPETENCE 36 0.0045
98 BACTERIAL TEST POSITIVE 10 0.0045
99 BLOOD MAGNESIUM INCREASED 4 0.0044
100 NIGHT BLINDNESS 7 0.0044
101 EMERGENCY CARE 13 0.0043
102 MEAN CELL HAEMOGLOBIN INCREASED 7 0.0042
103 CERVICAL RADICULOPATHY 3 0.0042
104 LARYNGEAL DISORDER 3 0.0042
105 LUMBAR SPINAL STENOSIS 12 0.0041
106 ABDOMINAL WALL HAEMATOMA 8 0.0041
107 AORTIC VALVE SCLEROSIS 3 0.0041
108 ATRIAL FIBRILLATION 397 0.0041
109 ATRIOVENTRICULAR BLOCK COMPLETE 27 0.0040
110 CARDIAC INFECTION 3 0.0040
111 HEART SOUNDS ABNORMAL 3 0.0040
112 AUTONOMIC NEUROPATHY 4 0.0039
113 ASPIRATION PLEURAL CAVITY 3 0.0039
114 MEAN CELL VOLUME INCREASED 10 0.0039
115 HYPERTROPHIC CARDIOMYOPATHY 6 0.0039
116 CARDIAC VENTRICULAR THROMBOSIS 5 0.0039
117 LIGHT CHAIN ANALYSIS INCREASED 4 0.0039
118 GASTROSTOMY 6 0.0039
119 CARDIAC FAILURE CONGESTIVE 308 0.0038
120 SINUS ARREST 6 0.0038
121 URINE KETONE BODY PRESENT 6 0.0038
122 CARPAL TUNNEL DECOMPRESSION 4 0.0038
123 DEATH 3266 0.0038
124 CARDIAC DYSFUNCTION 14 0.0038
125 PRODUCT SIZE ISSUE 20 0.0037
126 ARRHYTHMIA SUPRAVENTRICULAR 4 0.0037
127 EARLY SATIETY 7 0.0036
128 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
129 DYSGRAPHIA 23 0.0035
130 PULMONARY VALVE INCOMPETENCE 5 0.0034
131 HEART RATE ABNORMAL 19 0.0034
132 AORTIC VALVE STENOSIS 6 0.0034
133 ATRIOVENTRICULAR BLOCK 26 0.0034
134 ATRIAL TACHYCARDIA 7 0.0033
135 DYSPNOEA EXERTIONAL 124 0.0033
136 CONDUCTION DISORDER 6 0.0033
137 GASTRIC OPERATION 3 0.0033
138 HAEMATOLOGICAL INFECTION 8 0.0033
139 EJECTION FRACTION ABNORMAL 4 0.0033
140 PROTEIN URINE PRESENT 16 0.0032
141 WHITE BLOOD CELLS URINE POSITIVE 6 0.0032
142 VENTRICULAR HYPERTROPHY 8 0.0032
143 POLYNEUROPATHY 38 0.0032
144 CEREBRAL PALSY 3 0.0032
145 TROPONIN T INCREASED 4 0.0032
146 GLUCOSE URINE PRESENT 4 0.0031
147 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
148 BENIGN PROSTATIC HYPERPLASIA 16 0.0031
149 CARDIAC DISORDER 288 0.0031
150 NEAR DEATH EXPERIENCE 10 0.0030
151 CARDIAC OPERATION 26 0.0030
152 RENAL CYST 24 0.0030
153 GOUT 54 0.0030
154 HEART RATE IRREGULAR 68 0.0030
155 NECK SURGERY 7 0.0030
156 TROPONIN I INCREASED 5 0.0030
157 WEIGHT FLUCTUATION 31 0.0030
158 PERIPHERAL VENOUS DISEASE 12 0.0029
159 CHANGE OF BOWEL HABIT 6 0.0029
160 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
161 GASTROINTESTINAL TUBE INSERTION 7 0.0028
162 CARDIOMYOPATHY 40 0.0027
163 EJECTION FRACTION DECREASED 42 0.0027
164 HYPERLIPIDAEMIA 32 0.0027
165 URINE ANALYSIS ABNORMAL 8 0.0027
166 HYPERTENSIVE HEART DISEASE 5 0.0027
167 STENOSIS 5 0.0027
168 ATRIOVENTRICULAR BLOCK SECOND DEGREE 8 0.0026
169 PALLIATIVE CARE 4 0.0026
170 BUNDLE BRANCH BLOCK LEFT 11 0.0026
171 ARTERIOSCLEROSIS 24 0.0025
172 SPINAL OPERATION 31 0.0025
173 TROPONIN INCREASED 19 0.0025
174 CARDIAC FLUTTER 16 0.0025
175 MITRAL VALVE INCOMPETENCE 28 0.0025
176 NIPPLE PAIN 5 0.0025
177 SHOULDER FRACTURE 4 0.0024
178 HEART VALVE INCOMPETENCE 7 0.0024
179 BRADYARRHYTHMIA 4 0.0024
180 FRACTURED COCCYX 3 0.0024
181 PROSTATIC DISORDER 13 0.0024
182 SKIN WOUND 4 0.0024
183 BLOOD BILIRUBIN ABNORMAL 3 0.0023
184 BLADDER NEOPLASM 4 0.0023
185 BLOOD CHLORIDE DECREASED 6 0.0023
186 MIXED LIVER INJURY 7 0.0023
187 VENTRICULAR TACHYCARDIA 38 0.0023
188 ARTERIOSCLEROSIS CORONARY ARTERY 15 0.0023
189 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
190 SKIN LACERATION 24 0.0022
191 ILLNESS 227 0.0022
192 ENERGY INCREASED 13 0.0022
193 BRADYKINESIA 13 0.0022
194 LIVER TRANSPLANT 8 0.0022
195 DIALYSIS 31 0.0022
196 VENTRICULAR HYPOKINESIA 7 0.0022
197 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
198 THERAPEUTIC RESPONSE UNEXPECTED 97 0.0022
199 ECHOCARDIOGRAM ABNORMAL 3 0.0021
200 WALKING AID USER 14 0.0021
201 OXYGEN SATURATION ABNORMAL 6 0.0021
202 INTENTIONAL DOSE OMISSION 60 0.0021
203 GENITAL RASH 3 0.0021
204 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
205 PERICARDIAL EFFUSION 48 0.0021
206 CARDIAC FIBRILLATION 3 0.0020
207 GLOMERULONEPHRITIS 5 0.0020
208 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
209 PROSTATOMEGALY 8 0.0020
210 VOCAL CORD DISORDER 4 0.0020
211 HOSPICE CARE 20 0.0020
212 DIPLEGIA 4 0.0020
213 INTERNAL HAEMORRHAGE 23 0.0020
214 CAROTID ARTERY STENOSIS 7 0.0020
215 POOR QUALITY PRODUCT ADMINISTERED 21 0.0020
216 CARDIAC DISCOMFORT 4 0.0020
217 ORGAN FAILURE 8 0.0020
218 CRANIOCEREBRAL INJURY 6 0.0020
219 DYSPHAGIA 188 0.0020
220 BACK DISORDER 32 0.0020
221 ENDOCARDITIS 10 0.0019
222 VENTRICULAR DYSFUNCTION 5 0.0019
223 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
224 DEAFNESS 49 0.0019
225 RENAL DISORDER 87 0.0019
226 HIP FRACTURE 60 0.0019
227 PULMONARY OEDEMA 83 0.0019
228 BLOOD UREA INCREASED 31 0.0018
229 HEART RATE DECREASED 65 0.0018
230 PRODUCT USE COMPLAINT 29 0.0018
231 PRODUCT DOSE OMISSION IN ERROR 52 0.0018
232 KNEE OPERATION 18 0.0018
233 OESOPHAGEAL DISORDER 7 0.0018
234 DISEASE PROGRESSION 214 0.0018
235 GASTRIC DILATATION 3 0.0018
236 PROSTATE CANCER METASTATIC 6 0.0018
237 URINE ABNORMALITY 8 0.0018
238 CARDIAC VALVE DISEASE 10 0.0017
239 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
240 CERVICAL VERTEBRAL FRACTURE 6 0.0017
241 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
242 PERIPHERAL SWELLING 265 0.0017
243 RHABDOMYOLYSIS 70 0.0017
244 WEIGHT ABNORMAL 4 0.0017
245 SPONDYLITIS 6 0.0016
246 SUDDEN DEATH 17 0.0016
247 ACUTE PULMONARY OEDEMA 9 0.0016
248 PROTEIN TOTAL DECREASED 6 0.0016
249 ACCIDENT 19 0.0016
250 INFECTED SKIN ULCER 3 0.0016
251 HIP ARTHROPLASTY 24 0.0016
252 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
253 EXERCISE TOLERANCE DECREASED 9 0.0016
254 CEREBROVASCULAR ACCIDENT 264 0.0016
255 RALES 9 0.0015
256 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
257 THERAPY INTERRUPTED 109 0.0015
258 SUSPECTED COVID-19 5 0.0015
259 PLEURAL EFFUSION 92 0.0015
260 ARTHRITIS INFECTIVE 7 0.0015
261 SKIN INJURY 5 0.0015
262 BLOOD POTASSIUM ABNORMAL 4 0.0015
263 GAIT INABILITY 50 0.0015
264 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
265 FOAMING AT MOUTH 3 0.0015
266 GALLBLADDER OPERATION 6 0.0015
267 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
268 SPINAL OSTEOARTHRITIS 13 0.0015
269 KNEE ARTHROPLASTY 31 0.0015
270 SUDDEN CARDIAC DEATH 5 0.0015
271 HEAD INJURY 46 0.0015
272 NEUROPATHY PERIPHERAL 138 0.0014
273 SINUS BRADYCARDIA 14 0.0014
274 VENTRICULAR EXTRASYSTOLES 15 0.0014
275 PRE-EXISTING CONDITION IMPROVED 9 0.0014
276 CHOLECYSTITIS INFECTIVE 4 0.0014
277 FALL 479 0.0014
278 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
279 DYSPNOEA 804 0.0014
280 EYE CONTUSION 3 0.0014
281 CEREBRAL THROMBOSIS 4 0.0014
282 AORTIC VALVE INCOMPETENCE 6 0.0014
283 GLOSSITIS 5 0.0014
284 DEREALISATION 3 0.0014
285 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
286 HYPOVOLAEMIA 8 0.0014
287 JOINT INJURY 29 0.0014
288 WHEELCHAIR USER 6 0.0013
289 BLOOD CULTURE POSITIVE 4 0.0013
290 BALANCE DISORDER 115 0.0013
291 GASTRIC POLYPS 3 0.0013
292 COVID-19 232 0.0013
293 FACE INJURY 5 0.0013
294 HAEMATOCRIT INCREASED 3 0.0013
295 BRAIN OPERATION 3 0.0013
296 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
297 INTRACARDIAC THROMBUS 4 0.0013
298 HIP SURGERY 7 0.0013
299 RHINOVIRUS INFECTION 5 0.0013
300 CHOKING 25 0.0013
301 HEPATIC CIRRHOSIS 24 0.0013
302 BLOOD SODIUM DECREASED 24 0.0013
303 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 61 0.0013
304 SKIN ABRASION 6 0.0013
305 CEREBRAL INFARCTION 31 0.0013
306 LIMB OPERATION 6 0.0012
307 VITAMIN B12 DEFICIENCY 5 0.0012
308 BLOOD POTASSIUM INCREASED 20 0.0012
309 ARRHYTHMIA 58 0.0012
310 DEAFNESS NEUROSENSORY 4 0.0012
311 DECREASED ACTIVITY 13 0.0012
312 RENAL IMPAIRMENT 101 0.0012
313 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
314 FLUID INTAKE REDUCED 6 0.0012
315 OEDEMA PERIPHERAL 146 0.0012
316 LABYRINTHITIS 3 0.0012
317 AORTIC ANEURYSM 9 0.0012
318 LIMB INJURY 32 0.0012
319 BOWEL MOVEMENT IRREGULARITY 9 0.0012
320 ABDOMINAL INFECTION 3 0.0012
321 SHOULDER OPERATION 5 0.0012
322 AORTIC ARTERIOSCLEROSIS 3 0.0012
323 CONCUSSION 9 0.0012
324 VARICOSE VEIN 6 0.0012
325 OEDEMA 63 0.0012
326 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
327 FAILURE TO THRIVE 6 0.0012
328 HERNIA REPAIR 3 0.0012
329 HYPERSENSITIVITY VASCULITIS 3 0.0011
330 GAIT DISTURBANCE 217 0.0011
331 GENERALISED OEDEMA 14 0.0011
332 BLOOD CREATINE INCREASED 5 0.0011
333 HAEMORRHAGIC DIATHESIS 4 0.0011
334 FRUSTRATION TOLERANCE DECREASED 9 0.0011
335 IRON DEFICIENCY 5 0.0011
336 HAEMATOCRIT DECREASED 22 0.0011
337 RENAL TRANSPLANT 4 0.0011
338 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
339 NONSPECIFIC REACTION 6 0.0011
340 WEIGHT DECREASED 302 0.0011
341 WOUND HAEMORRHAGE 4 0.0011
342 ELECTRIC SHOCK SENSATION 3 0.0011
343 SCIATICA 17 0.0011
344 PERIORBITAL SWELLING 6 0.0011
345 SPEECH DISORDER 55 0.0010
346 PRODUCT PRESCRIBING ERROR 25 0.0010
347 TERMINAL STATE 7 0.0010
348 CARDIOGENIC SHOCK 15 0.0010
349 FIBULA FRACTURE 3 0.0010
350 HUMERUS FRACTURE 5 0.0010
351 DYSPNOEA AT REST 3 0.0010
352 FEEDING DISORDER 21 0.0010
353 ULCER HAEMORRHAGE 7 0.0010
354 LOCALISED INFECTION 25 0.0010
355 ORTHOSTATIC HYPOTENSION 18 0.0010
356 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
357 EATING DISORDER 22 0.0010
358 PELVIC FRACTURE 8 0.0010
359 VITAMIN D DEFICIENCY 10 0.0010
360 CORONARY ARTERY DISEASE 31 0.0010
361 CONDITION AGGRAVATED 311 0.0010
362 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
363 COVID-19 PNEUMONIA 12 0.0010
364 BLOOD CREATININE INCREASED 66 0.0010
365 BLADDER DISORDER 10 0.0010
366 ABDOMINAL TENDERNESS 5 0.0010
367 MEMORY IMPAIRMENT 138 0.0010
368 CHRONIC KIDNEY DISEASE 76 0.0010
369 BLOOD DISORDER 8 0.0010
370 HAND FRACTURE 7 0.0010
371 DYSLIPIDAEMIA 5 0.0010
372 DYSCHEZIA 3 0.0010
373 DECUBITUS ULCER 8 0.0010
374 DIABETIC FOOT 3 0.0010
375 TRIGGER FINGER 4 0.0010
376 RENAL FAILURE 129 0.0010
377 BRAIN FOG 15 0.0010
378 URINARY TRACT INFECTION 162 0.0009
379 ELECTROLYTE IMBALANCE 11 0.0009
380 PERIPHERAL COLDNESS 13 0.0009
381 INTERVERTEBRAL DISC DISORDER 4 0.0009
382 ACUTE RESPIRATORY FAILURE 18 0.0009
383 OVERWEIGHT 5 0.0009
384 ARTHRITIS 73 0.0009
385 METASTATIC NEOPLASM 4 0.0009
386 RIB FRACTURE 19 0.0009
387 LIGAMENT SPRAIN 9 0.0009
388 BLINDNESS 37 0.0009
389 CORONAVIRUS INFECTION 6 0.0009
390 BLOOD PRESSURE ABNORMAL 18 0.0009
391 FEMUR FRACTURE 28 0.0009
392 UPPER LIMB FRACTURE 18 0.0009
393 FRACTURE 17 0.0009
394 HAEMORRHAGIC STROKE 7 0.0009
395 HOSPITALISATION 137 0.0009
396 DYSSTASIA 26 0.0009
397 ASCITES 26 0.0009
398 CARDIAC ARREST 73 0.0009
399 ASTHENIA 332 0.0009
400 BLOOD ALBUMIN DECREASED 7 0.0009
401 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
402 MYOCARDIAL ISCHAEMIA 10 0.0009
403 PRODUCT DOSE OMISSION ISSUE 257 0.0009
404 DISEASE COMPLICATION 4 0.0009
405 IMMUNE THROMBOCYTOPENIA 4 0.0009
406 GASTROINTESTINAL DISORDER 78 0.0009
407 INCREASED TENDENCY TO BRUISE 8 0.0009
408 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
409 MUSCLE ATROPHY 11 0.0009
410 STENT PLACEMENT 7 0.0009
411 BLOOD CREATININE ABNORMAL 3 0.0009
412 RENAL FUNCTION TEST ABNORMAL 4 0.0009
413 BLOOD TEST ABNORMAL 12 0.0009
414 URINE ODOUR ABNORMAL 5 0.0008
415 DECREASED INTEREST 5 0.0008
416 BLOOD PRESSURE DECREASED 56 0.0008
417 LIMB DISCOMFORT 26 0.0008
418 FAECES DISCOLOURED 18 0.0008
419 BACK INJURY 9 0.0008
420 FAECES SOFT 6 0.0008
421 NOCTURIA 10 0.0008
422 CONFUSIONAL STATE 133 0.0008
423 CAROTID ARTERY OCCLUSION 3 0.0008
424 INGUINAL HERNIA 5 0.0008
425 CUTANEOUS VASCULITIS 3 0.0008
426 PNEUMOTHORAX 13 0.0008
427 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
428 PULMONARY HYPERTENSION 17 0.0008
429 OBESITY 13 0.0008
430 CELLULITIS 41 0.0008
431 SENSITIVE SKIN 6 0.0008
432 HAEMATOMA 21 0.0008
433 MOVEMENT DISORDER 26 0.0008
434 URINARY RETENTION 27 0.0008
435 NEOPLASM MALIGNANT 54 0.0008
436 CATARACT 48 0.0008
437 ANEURYSM 4 0.0008
438 INFUSION SITE EXTRAVASATION 5 0.0008
439 MALAISE 349 0.0008
440 LOSS OF CONTROL OF LEGS 3 0.0008
441 CORONARY ARTERIAL STENT INSERTION 4 0.0008
442 TOE AMPUTATION 4 0.0008
443 HYPOTENSION 158 0.0008
444 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
445 COMMUNICATION DISORDER 3 0.0008
446 AMMONIA INCREASED 4 0.0008
447 DRUG INTERACTION 124 0.0008
448 PRESYNCOPE 19 0.0008
449 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
450 SEPSIS 87 0.0008
451 ROTATOR CUFF SYNDROME 10 0.0008
452 HERNIA 15 0.0008
453 COGNITIVE DISORDER 36 0.0008
454 ACUTE KIDNEY INJURY 116 0.0008
455 DISEASE RECURRENCE 36 0.0008
456 OFF LABEL USE 661 0.0008
457 HYPOTHYROIDISM 24 0.0008
458 FATIGUE 585 0.0008
459 SYNCOPE 75 0.0007
460 FOOD POISONING 4 0.0007
461 COMPRESSION FRACTURE 4 0.0007
462 SQUAMOUS CELL CARCINOMA 7 0.0007
463 HYPERKALAEMIA 26 0.0007
464 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
465 POLYURIA 6 0.0007
466 PNEUMONIA 237 0.0007
467 CARDIOMEGALY 9 0.0007
468 ARTHRITIS BACTERIAL 3 0.0007
469 HICCUPS 6 0.0007
470 ASPIRATION 8 0.0007
471 FAECALOMA 4 0.0007
472 TENDON RUPTURE 9 0.0007
473 LOWER LIMB FRACTURE 14 0.0007
474 HYPERCHOLESTEROLAEMIA 7 0.0007
475 LYMPHOEDEMA 5 0.0007
476 LARGE INTESTINE POLYP 5 0.0007
477 AGEUSIA 18 0.0007
478 HEMIPLEGIA 6 0.0007
479 CONGESTIVE CARDIOMYOPATHY 3 0.0007
480 SWELLING 67 0.0007
481 DIZZINESS 357 0.0007
482 PHARYNGEAL SWELLING 7 0.0007
483 KIDNEY INFECTION 14 0.0007
484 DEHYDRATION 94 0.0007
485 IMPAIRED DRIVING ABILITY 8 0.0007
486 NEURALGIA 17 0.0007
487 LIVER FUNCTION TEST INCREASED 15 0.0007
488 BRAIN INJURY 7 0.0007
489 BACTERIAL INFECTION 13 0.0007
490 POOR QUALITY SLEEP 15 0.0007
491 BONE CANCER 3 0.0007
492 SLUGGISHNESS 7 0.0007
493 FOOT FRACTURE 13 0.0007
494 MAJOR DEPRESSION 5 0.0007
495 MUSCULOSKELETAL DISORDER 13 0.0007
496 MOUTH HAEMORRHAGE 5 0.0007
497 LABORATORY TEST ABNORMAL 20 0.0007
498 CATHETERISATION CARDIAC 3 0.0007
499 PETECHIAE 7 0.0007
500 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
501 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
502 ABDOMINAL DISTENSION 70 0.0007
503 CEREBRAL HAEMORRHAGE 24 0.0007
504 MACULAR DEGENERATION 8 0.0007
505 MOBILITY DECREASED 48 0.0007
506 WRIST FRACTURE 8 0.0007
507 ANAL INCONTINENCE 6 0.0007
508 THROMBOSIS 53 0.0007
509 HAEMOGLOBIN INCREASED 3 0.0007
510 HEPATOCELLULAR CARCINOMA 5 0.0007
511 LUMBAR VERTEBRAL FRACTURE 3 0.0007
512 PNEUMONIA BACTERIAL 6 0.0007
513 ISCHAEMIA 3 0.0007
514 EYE OPERATION 3 0.0007
515 THYROID DISORDER 10 0.0006
516 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
517 FEELING OF DESPAIR 3 0.0006
518 NEPHROPATHY 6 0.0006
519 APPENDICITIS 6 0.0006
520 BRADYCARDIA 34 0.0006
521 PNEUMONIA ASPIRATION 16 0.0006
522 MUSCULOSKELETAL DISCOMFORT 11 0.0006
523 FLATULENCE 36 0.0006
524 RED BLOOD CELL COUNT DECREASED 18 0.0006
525 ANGINA PECTORIS 18 0.0006
526 MALNUTRITION 7 0.0006
527 GLAUCOMA 12 0.0006
528 SENSORY LOSS 5 0.0006
529 AMNESIA 40 0.0006
530 SCAB 7 0.0006
531 MICTURITION URGENCY 7 0.0006
532 RENAL TUBULAR NECROSIS 6 0.0006
533 THERAPY CHANGE 6 0.0006
534 ESCHERICHIA INFECTION 5 0.0006
535 URINARY INCONTINENCE 18 0.0006
536 MUSCULAR WEAKNESS 69 0.0006
537 PULMONARY CONGESTION 8 0.0006
538 SPINAL COMPRESSION FRACTURE 5 0.0006
539 APPETITE DISORDER 4 0.0006
540 HAEMORRHAGE 63 0.0006
541 MYOCARDIAL INFARCTION 105 0.0006
542 SPINAL FRACTURE 12 0.0006
543 BLOOD POTASSIUM DECREASED 18 0.0006
544 GENERAL PHYSICAL HEALTH DETERIORATION 69 0.0006
545 BREAST MASS 4 0.0006
546 TASTE DISORDER 12 0.0006
547 CARDIOVASCULAR DISORDER 15 0.0006
548 HAEMATURIA 20 0.0006
549 INTENTIONAL PRODUCT MISUSE 51 0.0006
550 HYPOAESTHESIA 87 0.0006
551 WEIGHT INCREASED 130 0.0006
552 RESPIRATION ABNORMAL 4 0.0006
553 SKIN ULCER 15 0.0006
554 JOINT EFFUSION 4 0.0006
555 BLOOD URINE PRESENT 11 0.0006
556 CARDIAC MURMUR 5 0.0006
557 EYE DISORDER 19 0.0006
558 DIPLOPIA 15 0.0006
559 SLEEP APNOEA SYNDROME 11 0.0006
560 ARTHROPATHY 32 0.0006
561 APHONIA 8 0.0006
562 EXTRASYSTOLES 4 0.0006
563 CONTUSION 55 0.0006
564 SMALL INTESTINAL OBSTRUCTION 7 0.0006
565 FULL BLOOD COUNT ABNORMAL 6 0.0006
566 RENAL PAIN 6 0.0006
567 LYMPHOCYTE COUNT DECREASED 10 0.0006
568 HYPOKALAEMIA 26 0.0006
569 CHEST PAIN 104 0.0006
570 BLOOD BILIRUBIN INCREASED 15 0.0006
571 HAEMOGLOBIN DECREASED 57 0.0006
572 OROPHARYNGEAL DISCOMFORT 5 0.0006
573 BACK PAIN 128 0.0006
574 HYDROCEPHALUS 3 0.0006
575 GASTROINTESTINAL HAEMORRHAGE 46 0.0005
576 EPISTAXIS 41 0.0005
577 DYSPHONIA 32 0.0005
578 LOSS OF CONSCIOUSNESS 70 0.0005
579 ASTHENOPIA 3 0.0005
580 DEAFNESS UNILATERAL 3 0.0005
581 RETINAL DETACHMENT 5 0.0005
582 GASTRIC ULCER HAEMORRHAGE 3 0.0005
583 CEREBRAL DISORDER 4 0.0005
584 HIATUS HERNIA 7 0.0005
585 LETHARGY 31 0.0005
586 COLON CANCER 8 0.0005
587 THINKING ABNORMAL 10 0.0005
588 WOUND 15 0.0005
589 MENTAL IMPAIRMENT 13 0.0005
590 BEDRIDDEN 7 0.0005
591 PAROSMIA 4 0.0005
592 LEUKAEMIA 5 0.0005
593 INFLUENZA 59 0.0005
594 POLLAKIURIA 22 0.0005
595 NEPHROLITHIASIS 24 0.0005
596 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
597 PROCEDURAL COMPLICATION 4 0.0005
598 VISUAL IMPAIRMENT 64 0.0005
599 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
600 PAIN IN EXTREMITY 151 0.0005
601 EXPIRED PRODUCT ADMINISTERED 17 0.0005
602 CORONARY ARTERY OCCLUSION 7 0.0005
603 SKIN LESION 14 0.0005
604 HYPERCHLORHYDRIA 3 0.0005
605 HEAD DISCOMFORT 9 0.0005
606 SEPTIC SHOCK 22 0.0005
607 MENTAL DISORDER 22 0.0005
608 RESPIRATORY DISORDER 15 0.0005
609 OXYGEN SATURATION DECREASED 28 0.0005
610 SLEEP DISORDER 35 0.0005
611 OSTEOARTHRITIS 21 0.0005
612 DECREASED APPETITE 115 0.0005
613 SURGERY 29 0.0005
614 MUSCLE DISORDER 4 0.0005
615 SHOCK HAEMORRHAGIC 4 0.0005
616 INFECTION 71 0.0005
617 ASPHYXIA 4 0.0005
618 SUBDURAL HAEMATOMA 7 0.0005
619 HYPERAESTHESIA 4 0.0005
620 HELICOBACTER INFECTION 5 0.0005
621 HYPERTENSION 103 0.0005
622 CONSTIPATION 106 0.0005
623 TEMPERATURE INTOLERANCE 5 0.0005
624 SOMNOLENCE 97 0.0005
625 COUGH 135 0.0005
626 INTESTINAL OBSTRUCTION 18 0.0005
627 INFUSION SITE SWELLING 3 0.0005
628 SENSATION OF FOREIGN BODY 4 0.0005
629 DIABETES MELLITUS 36 0.0005
630 INCREASED APPETITE 9 0.0005
631 HAEMOPTYSIS 13 0.0005
632 HEPATITIS ACUTE 3 0.0005
633 PULMONARY THROMBOSIS 5 0.0005
634 BLOOD PRESSURE FLUCTUATION 11 0.0005
635 BLOOD CALCIUM INCREASED 4 0.0005
636 HEART RATE INCREASED 45 0.0005
637 TOOTH FRACTURE 5 0.0005
638 MUSCULOSKELETAL CHEST PAIN 7 0.0005
639 TOOTH DISORDER 10 0.0004
640 GALLBLADDER DISORDER 8 0.0004
641 ABNORMAL LOSS OF WEIGHT 3 0.0004
642 CYSTITIS 14 0.0004
643 END STAGE RENAL DISEASE 8 0.0004
644 LUNG NEOPLASM MALIGNANT 18 0.0004
645 SHOCK 10 0.0004
646 RESPIRATORY DISTRESS 12 0.0004
647 GASTRIC HAEMORRHAGE 5 0.0004
648 HAIR GROWTH ABNORMAL 3 0.0004
649 IRON DEFICIENCY ANAEMIA 4 0.0004
650 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
651 HYPOMAGNESAEMIA 6 0.0004
652 POST PROCEDURAL HAEMORRHAGE 5 0.0004
653 LUNG DISORDER 21 0.0004
654 LIVER DISORDER 19 0.0004
655 ERECTILE DYSFUNCTION 11 0.0004
656 FLANK PAIN 4 0.0004
657 MULTIPLE FRACTURES 7 0.0004
658 GASTRIC ULCER 8 0.0004
659 SKIN DISORDER 14 0.0004
660 HYPERSOMNIA 12 0.0004
661 RHINORRHOEA 27 0.0004
662 CHOLESTASIS 8 0.0004
663 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
664 ANOSMIA 6 0.0004
665 HYPERTHYROIDISM 6 0.0004
666 ATELECTASIS 4 0.0004
667 SKIN DISCOLOURATION 19 0.0004
668 PRODUCT DISPENSING ERROR 9 0.0004
669 FLUID OVERLOAD 6 0.0004
670 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
671 MELAENA 9 0.0004
672 DYSURIA 15 0.0004
673 SINUS DISORDER 8 0.0004
674 PRODUCT USE IN UNAPPROVED INDICATION 100 0.0004
675 CYST 5 0.0004
676 INABILITY TO AFFORD MEDICATION 4 0.0004
677 ILEUS 5 0.0004
678 TOOTH EXTRACTION 5 0.0004
679 CHROMATURIA 9 0.0004
680 HEPATIC FAILURE 12 0.0004
681 APHASIA 12 0.0004
682 DEPRESSED MOOD 21 0.0004
683 EMPHYSEMA 4 0.0004
684 RECTAL HAEMORRHAGE 17 0.0004
685 HAEMATEMESIS 10 0.0004
686 TACHYCARDIA 35 0.0004
687 DRY THROAT 4 0.0004
688 NEUTROPHIL COUNT INCREASED 4 0.0004
689 LYMPHOMA 6 0.0004
690 ANKLE FRACTURE 6 0.0004
691 ROAD TRAFFIC ACCIDENT 16 0.0004
692 JOINT DISLOCATION 4 0.0004
693 QUALITY OF LIFE DECREASED 5 0.0004
694 INSOMNIA 99 0.0004
695 PHARYNGITIS STREPTOCOCCAL 4 0.0004
696 PROTEINURIA 7 0.0004
697 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
698 PULMONARY FIBROSIS 7 0.0004
699 ABDOMINAL DISCOMFORT 61 0.0004
700 ILL-DEFINED DISORDER 22 0.0004
701 DIVERTICULITIS 10 0.0004
702 VIRAL INFECTION 12 0.0004
703 NERVE INJURY 4 0.0004
704 FEELING ABNORMAL 86 0.0004
705 CARDIO-RESPIRATORY ARREST 15 0.0004
706 MASS 5 0.0004
707 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
708 SKIN INFECTION 4 0.0004
709 TYPE 2 DIABETES MELLITUS 12 0.0004
710 JOINT SWELLING 43 0.0004
711 PRODUCTIVE COUGH 17 0.0004
712 TREMOR 59 0.0004
713 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
714 REBOUND EFFECT 4 0.0004
715 DIARRHOEA 228 0.0004
716 HYPOPHAGIA 9 0.0004
717 THERAPY CESSATION 18 0.0004
718 PARALYSIS 5 0.0003
719 UNRESPONSIVE TO STIMULI 9 0.0003
720 PROSTATE CANCER 28 0.0003
721 BLOOD MAGNESIUM DECREASED 3 0.0003
722 PRODUCT PHYSICAL ISSUE 7 0.0003
723 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
724 APATHY 5 0.0003
725 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
726 SPINAL PAIN 4 0.0003
727 PLATELET COUNT DECREASED 36 0.0003
728 SKIN HAEMORRHAGE 5 0.0003
729 BLOOD IRON DECREASED 4 0.0003
730 BACTERAEMIA 4 0.0003
731 NASOPHARYNGITIS 62 0.0003
732 PULMONARY MASS 5 0.0003
733 HAEMARTHROSIS 3 0.0003
734 PALPITATIONS 39 0.0003
735 THYROID CANCER 4 0.0003
736 CHEST DISCOMFORT 34 0.0003
737 BONE DISORDER 6 0.0003
738 RESPIRATORY FAILURE 24 0.0003
739 ARTHRALGIA 136 0.0003
740 ENCEPHALOPATHY 8 0.0003
741 HEPATIC ENCEPHALOPATHY 3 0.0003
742 ANAEMIA 61 0.0003
743 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
744 RASH MACULAR 11 0.0003
745 ULCER 5 0.0003
746 HEPATIC CYTOLYSIS 4 0.0003
747 VERTIGO 19 0.0003
748 PANCREATIC CARCINOMA 9 0.0003
749 SENSORY DISTURBANCE 5 0.0003
750 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
751 LACTIC ACIDOSIS 10 0.0003
752 HAEMORRHOIDS 6 0.0003
753 NERVOUSNESS 16 0.0003
754 NECK PAIN 17 0.0003
755 TOOTH INFECTION 4 0.0003
756 HYPOTONIA 3 0.0003
757 FUNGAL INFECTION 10 0.0003
758 JOINT RANGE OF MOTION DECREASED 4 0.0003
759 EYE PRURITUS 10 0.0003
760 PRURITUS 114 0.0003
761 HYPOTHERMIA 3 0.0003
762 ABDOMINAL PAIN UPPER 61 0.0003
763 FREQUENT BOWEL MOVEMENTS 8 0.0003
764 CANDIDA INFECTION 5 0.0003
765 SINUS CONGESTION 4 0.0003
766 DEPRESSION 67 0.0003
767 BLOOD PRESSURE INCREASED 45 0.0003
768 TACHYPNOEA 4 0.0003
769 IMPAIRED GASTRIC EMPTYING 4 0.0003
770 GINGIVAL BLEEDING 4 0.0003
771 TREATMENT NONCOMPLIANCE 16 0.0003
772 EAR DISCOMFORT 3 0.0003
773 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
774 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
775 BLOOD GLUCOSE DECREASED 14 0.0003
776 VISION BLURRED 40 0.0003
777 HAEMATOCHEZIA 16 0.0003
778 HYPERBILIRUBINAEMIA 3 0.0003
779 MUSCLE SPASMS 53 0.0003
780 DELIRIUM 10 0.0003
781 COORDINATION ABNORMAL 4 0.0003
782 PARAESTHESIA 45 0.0003
783 HYPOXIA 10 0.0003
784 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
785 SEASONAL ALLERGY 4 0.0003
786 MYALGIA 48 0.0003
787 ISCHAEMIC STROKE 5 0.0003
788 BLOOD CHOLESTEROL INCREASED 13 0.0003
789 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
790 DISORIENTATION 11 0.0003
791 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
792 MYELODYSPLASTIC SYNDROME 4 0.0003
793 HYPOKINESIA 4 0.0003
794 RESTLESS LEGS SYNDROME 5 0.0003
795 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
796 ACCIDENTAL OVERDOSE 10 0.0003
797 GASTROINTESTINAL PAIN 3 0.0003
798 FOOT DEFORMITY 3 0.0003
799 BRONCHITIS 20 0.0003
800 INTERSTITIAL LUNG DISEASE 13 0.0003
801 ORAL PAIN 6 0.0003
802 HAEMORRHAGE INTRACRANIAL 4 0.0003
803 JOINT STIFFNESS 7 0.0003
804 HYPONATRAEMIA 15 0.0003
805 GASTRITIS 7 0.0003
806 EYE INFECTION 3 0.0003
807 DYSPEPSIA 26 0.0003
808 PULMONARY EMBOLISM 25 0.0003
809 DERMATITIS CONTACT 3 0.0003
810 CHOLECYSTECTOMY 3 0.0003
811 PAIN 161 0.0003
812 POST PROCEDURAL COMPLICATION 5 0.0003
813 DEVICE RELATED INFECTION 4 0.0003
814 EMOTIONAL DISORDER 8 0.0003
815 DRUG INTOLERANCE 25 0.0003
816 ERUCTATION 5 0.0003
817 RASH PRURITIC 14 0.0003
818 ASTHMA 29 0.0003
819 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
820 MENTAL STATUS CHANGES 7 0.0003
821 RESPIRATORY TRACT CONGESTION 4 0.0003
822 MUSCULOSKELETAL STIFFNESS 22 0.0003
823 PRESCRIBED UNDERDOSE 5 0.0003
824 HEPATIC ENZYME INCREASED 17 0.0002
825 BLISTER 14 0.0002
826 NIGHT SWEATS 8 0.0002
827 IMPAIRED HEALING 8 0.0002
828 LIVER FUNCTION TEST ABNORMAL 7 0.0002
829 PERICARDITIS 4 0.0002
830 ACUTE MYOCARDIAL INFARCTION 7 0.0002
831 HEMIPARESIS 4 0.0002
832 INJECTION SITE IRRITATION 3 0.0002
833 SKIN CANCER 5 0.0002
834 PARANOIA 4 0.0002
835 PRODUCT PRESCRIBING ISSUE 5 0.0002
836 ANXIETY 65 0.0002
837 BURNING SENSATION 16 0.0002
838 METASTASES TO LIVER 4 0.0002
839 HERPES ZOSTER 13 0.0002
840 EYE HAEMORRHAGE 3 0.0002
841 NERVOUS SYSTEM DISORDER 7 0.0002
842 MALIGNANT MELANOMA 3 0.0002
843 RASH PAPULAR 5 0.0002
844 SNEEZING 5 0.0002
845 BLOOD GLUCOSE INCREASED 42 0.0002
846 OSTEOMYELITIS 4 0.0002
847 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
848 BLOOD GLUCOSE ABNORMAL 4 0.0002
849 SEIZURE 25 0.0002
850 FEELING COLD 6 0.0002
851 DEEP VEIN THROMBOSIS 14 0.0002
852 HEPATIC FUNCTION ABNORMAL 8 0.0002
853 MIDDLE INSOMNIA 4 0.0002
854 INJURY 15 0.0002
855 HALLUCINATION 16 0.0002
856 HYPOCALCAEMIA 4 0.0002
857 FEELING JITTERY 4 0.0002
858 IMPAIRED QUALITY OF LIFE 3 0.0002
859 PRESCRIBED OVERDOSE 4 0.0002
860 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
861 GASTROENTERITIS 3 0.0002
862 ORAL HERPES 4 0.0002
863 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
864 DYSGEUSIA 15 0.0002
865 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
866 THROAT IRRITATION 9 0.0002
867 DRY EYE 10 0.0002
868 VOMITING 94 0.0002
869 LACRIMATION INCREASED 6 0.0002
870 FULL BLOOD COUNT DECREASED 4 0.0002
871 CHILLS 23 0.0002
872 RASH 85 0.0002
873 SWOLLEN TONGUE 6 0.0002
874 CYANOSIS 3 0.0002
875 SKIN EXFOLIATION 16 0.0002
876 HYPERSENSITIVITY 35 0.0002
877 RETCHING 4 0.0002
878 NASAL CONGESTION 11 0.0002
879 IMPAIRED WORK ABILITY 4 0.0002
880 BLADDER CANCER 11 0.0002
881 JAUNDICE 5 0.0002
882 PAIN OF SKIN 5 0.0002
883 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
884 RESPIRATORY ARREST 5 0.0002
885 DRUG LEVEL INCREASED 3 0.0002
886 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
887 AGITATION 13 0.0002
888 PYREXIA 61 0.0002
889 MUSCLE TWITCHING 4 0.0002
890 DYSKINESIA 7 0.0002
891 UNEVALUABLE EVENT 13 0.0002
892 OSTEOPOROSIS 7 0.0002
893 DRUG INEFFECTIVE 222 0.0002
894 DISTURBANCE IN ATTENTION 9 0.0002
895 HEPATIC CANCER 4 0.0002
896 PANIC ATTACK 6 0.0002
897 CONJUNCTIVITIS 3 0.0002
898 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
899 GASTRIC CANCER 4 0.0002
900 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
901 NAUSEA 123 0.0002
902 BONE PAIN 9 0.0002
903 MUCOSAL INFLAMMATION 4 0.0002
904 MUSCULOSKELETAL PAIN 8 0.0002
905 CHOLELITHIASIS 5 0.0002
906 THROMBOCYTOPENIA 17 0.0002
907 ADVERSE EVENT 14 0.0002
908 WHEEZING 9 0.0002
909 HEADACHE 92 0.0001
910 HOT FLUSH 11 0.0001
911 GASTRIC DISORDER 5 0.0001
912 PRODUCT USE ISSUE 27 0.0001
913 HALLUCINATION, VISUAL 3 0.0001
914 ABDOMINAL PAIN 33 0.0001
915 OESOPHAGEAL CARCINOMA 4 0.0001
916 RENAL INJURY 4 0.0001
917 GLOSSODYNIA 3 0.0001
918 DYSARTHRIA 5 0.0001
919 SKIN IRRITATION 6 0.0001
920 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
921 DRUG-INDUCED LIVER INJURY 4 0.0001
922 SINUSITIS 13 0.0001
923 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
924 MOOD SWINGS 4 0.0001
925 OVERDOSE 27 0.0001
926 HYPERHIDROSIS 16 0.0001
927 SWELLING FACE 8 0.0001
928 STAPHYLOCOCCAL INFECTION 4 0.0001
929 STOMATITIS 7 0.0001
930 LYMPHADENOPATHY 4 0.0001
931 DRY SKIN 15 0.0001
932 ERYTHEMA 23 0.0001
933 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
934 DRY MOUTH 9 0.0001
935 CRYING 4 0.0001
936 INFLUENZA LIKE ILLNESS 9 0.0001
937 ABNORMAL DREAMS 3 0.0001
938 OROPHARYNGEAL PAIN 10 0.0001
939 PANCYTOPENIA 6 0.0001
940 COMA 5 0.0001
941 RASH ERYTHEMATOUS 5 0.0001
942 PRODUCT STORAGE ERROR 9 0.0001
943 ALOPECIA 20 0.0001
944 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
945 AGGRESSION 5 0.0001
946 IRRITABILITY 6 0.0001
947 DISCOMFORT 6 0.0001
948 FEELING HOT 6 0.0001
949 GYNAECOMASTIA 3 0.0001
950 INFLAMMATION 5 0.0001
951 WITHDRAWAL SYNDROME 4 0.0001
952 PANCREATITIS 5 0.0001
953 MIGRAINE 9 0.0001
954 INFUSION RELATED REACTION 6 0.0001
955 ANGIOEDEMA 4 0.0001
956 ADVERSE DRUG REACTION 8 0.0001
957 EYE PAIN 5 0.0001
958 TINNITUS 4 0.0001
959 DEVICE MALFUNCTION 6 0.0001
960 RENAL CANCER 4 0.0001
961 SKIN BURNING SENSATION 6 0.0001
962 URTICARIA 14 0.0001
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
964 LEUKOPENIA 4 0.0001
965 COLITIS 3 0.0001
966 SUICIDAL IDEATION 7 0.0001
967 ECZEMA 4 0.0001
968 INJECTION SITE PRURITUS 5 0.0001
969 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
970 NO ADVERSE EVENT 12 0.0001
971 THERAPEUTIC RESPONSE DECREASED 4 0.0001
972 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
973 HYPOGLYCAEMIA 3 0.0001
974 RHEUMATOID ARTHRITIS 7 0.0001
975 TREATMENT FAILURE 5 0.0001
976 DRUG DEPENDENCE 9 0.0001
977 BREAST CANCER 5 0.0001
978 INJECTION SITE BRUISING 4 0.0001
979 TOXICITY TO VARIOUS AGENTS 7 0.0000
980 INJECTION SITE ERYTHEMA 5 0.0000
981 ACNE 3 0.0000
982 INCORRECT DOSE ADMINISTERED 9 0.0000
983 FLUSHING 4 0.0000
984 INJECTION SITE HAEMORRHAGE 3 0.0000
985 PRODUCT QUALITY ISSUE 5 0.0000
986 COMPLETED SUICIDE 3 0.0000
987 EMOTIONAL DISTRESS 4 0.0000
988 INJECTION SITE PAIN 10 0.0000
989 PSORIASIS 4 0.0000
990 NEUTROPENIA 4 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000